Related Experiment Video
Updated: Mar 23, 2026
CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer
Published on: June 9, 2018
Experimental neurotransplantation treatment for hereditary cerebellar ataxias
1Laboratory of Neurodegenerative Disorders, Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, 323 00 Pilsen, Czech Republic.
Abstract:
Hereditary cerebellar degenerations are a heterogeneous group of diseases often having a detrimental impact on patients' quality of life. Unfortunately, no sufficiently effective causal therapy is available for human patients at present. There are several therapies that have been shown to affect the pathogenetic process and thereby to delay the progress of the disease in mouse models of cerebellar ataxias. The second experimental therapeutic approach for hereditary cerebellar ataxias is neurotransplantation. Grafted cells might provide an effect via delivery of a scarce neurotransmitter, substitution of lost cells if functionally integrated and rescue or trophic support of degenerating cells. The results of cerebellar transplantation research over the past 30 years are reviewed here and potential benefits and limitations of neurotransplantation therapy are discussed.
Insights
Neurotransplantation shows promise for hereditary cerebellar ataxias, offering potential benefits like neurotransmitter delivery and cell support. This review examines 30 years of research into cerebellar transplantation therapies for these debilitating neurological disorders.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Hereditary cerebellar degenerations are a diverse group of diseases significantly impacting patient quality of life.
- Currently, no effective causal therapies exist for human patients suffering from these conditions.
- Mouse models of cerebellar ataxias show that some therapies can delay disease progression by targeting pathogenetic processes.
Purpose of the Study:
- To review the progress of cerebellar transplantation research over the past three decades.
- To discuss the potential benefits and limitations of neurotransplantation as a therapeutic strategy for hereditary cerebellar ataxias.
Main Methods:
- Comprehensive review of scientific literature on cerebellar transplantation research.
- Analysis of studies investigating the mechanisms and outcomes of grafted cells in cerebellar ataxia models.
Main Results:
- Neurotransplantation is an experimental therapeutic approach for hereditary cerebellar ataxias.
- Grafted cells may exert therapeutic effects through neurotransmitter delivery, functional integration and substitution of lost cells, or providing trophic support to degenerating neurons.
- Research over 30 years has explored various aspects of cerebellar transplantation.
Conclusions:
- Neurotransplantation holds potential as a future therapy for hereditary cerebellar degenerations.
- Further research is needed to overcome limitations and optimize neurotransplantation strategies.
- Understanding the mechanisms of grafted cells is crucial for developing effective treatments.
